Gilead Sciences reported $15.23B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acorda Therapeutics ACOR:US USD 82.12M 10.42M
Agios Pharmaceuticals AGIO:US USD 832.77M 47.84M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 1.4M
Amgen AMGN:US USD 22.19B 1.88B
Biogen BIIB:US USD 9.79B 25.4M
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Coherus Biosciences CHRS:US USD 381.23M 67.04M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Glaxosmithkline GSK:US GBP 20.77B 520M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Moderna Inc MRNA:US USD 13.43B 866M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Puma Biotechnology PBYI:US USD 134.28M 11.93M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Sangamo Biosciences SGMO:US USD 300.33M 36.29M
Sarepta Therapeutics SRPT:US USD 2.56B 68.07M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
United Therapeutics UTHR:US USD 3.38B 323.9M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M
YTE INCY:US USD 4.09B 271.74M